Let’s look at the key reasons that are pushing Tango Therapeutics Inc (TNGX) to new highs

Tango Therapeutics Inc (NASDAQ: TNGX) kicked off on Tuesday, up 11.41% from the previous trading day, before settling in for the closing price of $1.84. Over the past 52 weeks, TNGX has traded in a range of $1.03-$12.02.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 103.26%. While this was happening, its average annual earnings per share was recorded -14.29%. With a float of $58.92 million, this company’s outstanding shares have now reached $108.11 million.

Let’s determine the extent of company efficiency that accounts for 155 employees. In terms of profitability, gross margin is 83.79%, operating margin of -355.86%, and the pretax margin is -322.17%.

Tango Therapeutics Inc (TNGX) Breakdown of a Key Holders of the stock

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Tango Therapeutics Inc is 45.64%, while institutional ownership is 56.26%. The most recent insider transaction that took place on Feb 04 ’25, was worth 8,289. In this transaction General Counsel of this company sold 2,774 shares at a rate of $2.99, taking the stock ownership to the 68,570 shares. Before that another transaction happened on Feb 05 ’25, when Company’s General Counsel sold 2,556 for $3.16, making the entire transaction worth $8,081. This insider now owns 66,014 shares in total.

Tango Therapeutics Inc (TNGX) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -14.29% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.61% during the next five years compared to 7.47% growth over the previous five years of trading.

Tango Therapeutics Inc (NASDAQ: TNGX) Trading Performance Indicators

Take a look at Tango Therapeutics Inc’s (TNGX) current performance indicators. Last quarter, stock had a quick ratio of 6.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.42.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.21, a number that is poised to hit -0.35 in the next quarter and is forecasted to reach -1.32 in one year’s time.

Technical Analysis of Tango Therapeutics Inc (TNGX)

Looking closely at Tango Therapeutics Inc (NASDAQ: TNGX), its last 5-days average volume was 5.24 million, which is a jump from its year-to-date volume of 1.2 million. As of the previous 9 days, the stock’s Stochastic %D was 37.71%. Additionally, its Average True Range was 0.30.

During the past 100 days, Tango Therapeutics Inc’s (TNGX) raw stochastic average was set at 38.93%, which indicates a significant decrease from 51.78% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 216.73% in the past 14 days, which was higher than the 119.17% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $1.5000, while its 200-day Moving Average is $4.2900. However, in the short run, Tango Therapeutics Inc’s stock first resistance to watch stands at $2.2500. Second resistance stands at $2.4500. The third major resistance level sits at $2.6300. If the price goes on to break the first support level at $1.8800, it is likely to go to the next support level at $1.7000. Now, if the price goes above the second support level, the third support stands at $1.5000.

Tango Therapeutics Inc (NASDAQ: TNGX) Key Stats

The company with the Market Capitalisation of 222.21 million has total of 108,394K Shares Outstanding. Its annual sales at the moment are 42,070 K in contrast with the sum of -130,300 K annual income. Company’s last quarter sales were recorded 5,390 K and last quarter income was -39,880 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.